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Abstract
For years, the field of drug delivery has focused on (1) controlling the release of a therapeutic and (2) targeting the
therapeutic to a specific cell type. These research endeavors have concentrated mainly on the development of
new degradable polymers and molecule-labeled drug delivery vehicles. Recent interest in biomaterials that respond
to their environment have opened new methods to trigger the release of drugs and localize the therapeutic within
a particular site. These novel biomaterials, usually termed “smart” or “intelligent”, are able to deliver a therapeutic
agent based on either environmental cues or a remote stimulus. Stimuli-responsive materials could potentially elicit
a therapeutically effective dose without adverse side effects. Polymers responding to different stimuli, such as pH,
light, temperature, ultrasound, magnetism, or biomolecules have been investigated as potential drug delivery vehi-
cles. This review describes the most recent advances in “smart” drug delivery systems that respond to one or multi-
ple stimuli.
Introduction
Polymeric materials that respond to a stimulus are often
called “smart” or “intelligent” due to their intrinsic ability
to alter their physical or chemical properties. For the
majority of the polymers that fall into this category, the
response to a change in the surrounding environment is
not only quick, on the order of minutes [1,2] to hours
[3,4], but also reversible, mimicking the dynamics
observed in natural polymers, such as proteins, polysac-
charides, and nucleic acids in living organic systems [5].
The response to stimuli is manifested in many forms: indi-
vidual chain dimension/size, shape, surface characteristics,
secondary structure, solubility, and degree of intermolecu-
lar association. These unique capabilities have been
applied to a diverse range of applications, including: drug
delivery [4,6-8], diagnostics [9,10], biological coating tech-
nologies [11,12], biosensing [10,13], and microfluidics [14].
Conventional drug delivery methods physically entrap
molecules within a polymer lattice; drug is released
slowly by diffusion or upon degradation of the network.
These methods typically result in an early peak in
plasma drug concentration followed by a steady, linear
release. This is far from ideal because the local drug
concentration and location of delivery is not precisely
controlled. Below the therapeutic dose, the drug is inef-
fective whereas high concentrations of drug may be
toxic or lead to undesirable side effects. Polymers have
been used to tailor drug release, which maintains the
drug concentration within the desired therapeutic range.
However, such controlled release systems are insensitive
t om e t a b o l i cc h a n g e si nt h eb o d ya n da r eu n a b l et o
modulate drug release nor target the drug to diseased
tissue. This lack of control has motivated the exploita-
tion of bioresponsive polymers as drug carriers.
As early as the 1950 s, stimuli responsive hydrogels
have been studied for drug release [15]. Since then,
polymers that react to different stimuli have been devel-
oped. These stimuli include pH [16-20], ionic strength
[21], and the presence of metabolic chemicals (e.g.,
enzymes or antigens) [22,23]. Such stimuli may enable a
drug carrier to distinguish between diseased and healthy
tissue. More recently, drug carriers that respond to mag-
netic fields [24], light [25], radiation [26], and ultra-
sound [27] have also been developed. These external
stimuli allow for greater control over when and where
the drug is released. By tuning the formulation or che-
mical moieties of the polymer, the sensitivity to the sti-
muli can be precisely controlled. This review aims to
provide an overview of how responsive polymers may be
used to improve drug delivery.
Stimuli-responsive materials for drug delivery
pH-sensitive drug delivery
pH-sensitive polymers (see Table 1) have garnered much
attention in the fields of drug delivery [28,29], gene
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pH-sensitive polymers have weak acids or bases with
pKa values between 3 and 10 [32]. Carboxylic, sulfonate,
and primary or tertiary amino groups exhibit a change
in ionization state as a function of pH. Transitions in
solubility, conformation, and swelling arise due to
changes in ionization, where specific polymer groups
switch between a neutral and charged state (e.g., poly(N,
N-dimethylaminoethyl methacrylate (DMAEMA)
[33-35]) or a hydrophilic and hydrophobic state (e.g.,
poly(N-iso-propylacrylamide) (PNIPAm) [36-38]).
Eisenberg et al. investigated pH-sensitive polymer
swelling to control the release of drug molecules [15].
Since then, several biocompatible and biodegradable
pH-sensitive polymers have been developed. Unfortu-
nately, few pH-sensitive polymers have been used for
drug delivery systems because of their limited sensitivity
near the pH of blood (pH 7.4). For example, natural
polymers (alginate [39,40], chitosan [41,42], and carra-
geenan [43]) and synthesized polymers (poly(acrylic
acid) (AA) [44] and poly(methacrylic acid) (MAA) [45])
exhibit a high swelling property at high pH due to ioniz-
able functional groups on the polymer backbone or side
chain. These polymers are not responsive under most
physiological conditions, albeit the gastrointestinal
system.
Systemic delivery requires that drug carriers respond to
small changes in pH, near pH 7.4. In 2005, Heffernan
and Murthy developed an acid-sensitive biodegradable
drug delivery vehicle using poly(1,4-phenyleneacetone
dimethylene ketal) (PPADK), which contains ketal lin-
kages allowing for acid-catalyzed hydrolysis of the poly-
mer into low molecular weight hydrophilic compounds.
Thus, the release of drug molecules is accelerated under
acidic conditions [46]. You and Auguste synthesized a
series of pH-sensitive nanoparticles comprised of
DMAEMA and 2-hydroxyethyl methacrylate (HEMA)
(Figure 1) [3]. DMAEMA is a pH-responsive monomer
that has a tertiary amine functional group with a pKa of
7.5 [47]. In vitro results support that the drug would
remain within the particle during circulation; upon expo-
sure to a low pH environment (e.g., a tumor [48]), the
particle would swell resulting in release of the drug.
Monodisperse, pH-sensitive DMAEMA/HEMA nanocar-
riers encapsulating paclitaxel exhibited pH-dependent
release kinetics (Figure 2). The particles had a high
volume swelling ratio at low pH, low crosslinking density,
and high content of DMAEMA. A similar series of parti-
cles were used for gene delivery, where triggered release
of plasmid DNA within the low pH endosome was opti-
mized [49,50]. Plasmid DNA for green fluorescent pro-
tein was encapsulated. HeLa cells were successfully
Table 1 Stimuli-sensitive drug delivery.
Stimulus Carrier type Payload Reference
pH PPADK Dexamethasone [45]
DMAEMA/HEMA Paclitaxel [3]
PC/DAP liposomes siRNA [51]
Temperature PNIPAm/PLGA Paclitaxel [36]
MPPC/DPPC/HSPC/DSPEC-PEG-2000 Doxorubicin [54]
FA/PDMA/PNIPAm Dipyridamole [57]
Light Cu chlorophyllin/PNIPAm None reported [60]
Quinone-methide Nile Red [63]
Au/meso porous silica Paclitaxel [61]
Ultrasound Pluronic P105/N,N-diethylacrylamide Doxorubicin [66]
DPPC:DPPE-PEG2000 liposomes Calcein [67]
Glucose poly(methacrylic acid-g-ethylene glycol) with glucose oxidase, PNIPAm with
phenylboronic acid
Insulin [69-72]
PNIPAm or carboxymethyl dextran with con. A None reported [73,74]
Enzyme PEG diacrylate/human neutrophil elastase-sensitive peptide None reported [75]
Fibrin/b-nerve growth factor fusion proteins b-nerve growth factor [76]
sPLA2-degradable retinoid lipid pro-drug Retinoid lipid pro-drug [77]
Magnetic Magnetite Squalenoyl gemcitabine
(SQdFdC)
[78]
Poly[aniline-co-N-(1-one-butyric acid)] aniline (SPAnH)/iron oxide Epirubicin [79]
Polylactide/nanocrystalline magnetite Paclitaxel [80]
Egg-PC/maghemite/PAH/PSS Calcein [81]
You et al. Journal of Biological Engineering 2010, 4:15
http://www.jbioleng.org/content/4/1/15
Page 2 of 12transfected with a dependence on the swelling ratio and
crosslinking density (Figure 3).
pH-dependent liposomes have also been used to trig-
ger the release of drug within acidic environments.
Auguste et al. formulated liposomes with variable sur-
face charge by varying the lipid composition [51]. pH-
sensitive liposomes were composed of a zwitterionic
lipid (phosphatidylcholine) and a titratable lipid
(dimethylammonium propane) with a pKa of 6.7. This
allowed the liposome’s net charge to become cationic
upon decreasing the pH. pH-dependent liposomes may
be shielded from the immune system using poly(ethy-
lene glycol) (PEG)-b-polycation polymers. The polyca-
tion block electrostatically anchored the PEG polymer
to the liposome surface at pH 7.4, but released the
polymer at pH 5.5 due to electrostatic repulsion
between the cationic polymer and cationic liposome sur-
face. The triggered release of adsorbed PEG-b-polyca-
tion polymers from pH-dependent liposomes may
protect the drug carrier from immune recognition dur-
ing circulation (pH 7.4) and allow subsequent intracellu-
lar delivery of siRNA within the endosome. The bare
liposome maintains the membrane disruption/fusion
capability [52,53].
Temperature-sensitive drug delivery
Increases in temperature are associated with several dis-
ease states (e.g., cancer [54,55]). Thermo-responsive
drug carriers have been employed to release their pay-
load within environments above the physiological
Figure 1 Transmission electron microscope image of DMAEMA/HEMA nanoparticles used for drug delivery. Scale bar is 500 nm [3].
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transition in solution at a temperature known as the
lower critical solution temperature (LCST). For example,
PNIPAm, a well-studied thermo-responsive polymer,
undergoes a reversible phase transition in aqueous solu-
tion from hydrophilic to hydrophobic at its LCST of
approximately 32°C. Chemical modifications of PNIPAm
have been effective in controlling the LCST [56]. In
2005, Liu et al. synthesized poly(N-isopropylacrylamide-
co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glyco-
lide) micelles for controlled paclitaxel delivery [36].
Paclitaxel release was accelerated when the physiological
temperature was raised above the LCST. The paclitaxel-
loaded micelles were more effective in killing human
breast carcinoma cells at 39.5°C than 37°C. De and col-
leagues developed folate-conjugated, thermo-responsive
block copolymer micelles. Folate is known to bind to
several cancer cell types [57]. The drug release studies
from folate-conjugated PNIPAm-DMA micelles demon-
strated a temperature-responsive drug release. Delivery
of paclitaxel at the tumor site can alter the overall drug
biodistribution. Needham et al. developed temperature-
sensitive liposomes containing doxorubicin [54]. Their
liposome formulation, composed of 1-palmitoyl-2-
hydroxy-sn-glycero-3-phosphocholine (MPPC), 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), hydro-
genated soy sn-glycero-3-phosphocholine (HSPC), and
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-
polyethylene glycol 2000 (DSPE-PEG-2000), was opti-
mized to rapidly release the drug under mild hyperther-
mic temperatures (39°C to 40°C). Changing the drug
biodistribution can increase therapeutic efficacy.
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Figure 2 Triggered paclitaxel release was observed by incubating 10/90 (mol/mol) DMAEMA/HEMA nanoparticles crosslinked with 3
mol% TEGDMA for 2 hours at pH 7.4 (black triangle) followed by a reduction in pH to either 6.8 (black circle), 7.0 (black square), or
7.2 (black diamond) for 4 hours. The error is the standard deviation of the mean, where n = 3 [3].
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Light (ultraviolet or visible) is a desirable external stimu-
lus for drug delivery systems because it is inexpensive
and easily controlled. Light-sensitive drug carriers are
fabricated from polymers that contain photo-sensitizers
such as azobenzene, stilbene, and triphenylmethane
[37,58,59]. Suzuki and Tanaka have investigated visible
light-responsive hydrogels using the trisodium salt of
copper chlorophyllin in PNIPAm hydrogels [60]. When
light is applied to the hydrogels, the chromophore
absorbs the light, increasing the local temperature of the
hydrogel. The resulting temperature change alters the
swelling behavior. Vivero-Escoto et al. prepared gold-
capped mesoporous silica nanospheres for photo-
induced intracellular release of drugs in human cells
[61]. The 100 nm silica nanospheres were capped with 5
nm gold nanospheres and functionalized with a cationic
photo-reactive linker. Photoirradiation using ultraviolet
(UV) light for 10 min at 0.49 mW/cm
2 cleaved the
photolabile linker, causing uncapping of the silica due to
charge repulsion between the gold and silica nano-
spheres, allowing drug to be released [61,62]. Fomina et
al. developed a novel light-sensitive polymer containing
a quinone-methide moiety [63]. Nile Red, a hydrophobic
dye, was released from nanoparticles after only one min-
ute of 350 nm light exposure. Light can be effective in
modulating drug release because it can be used to
increase the local temperature and to cleave bonds.
Ultrasound-sensitive drug delivery
Ultrasound has been shown to trigger drug release by
raising the local temperature or causing cavitation [64].
Both processes can increase the permeability of cell
membranes and accelerate polymer degradation [65].
Ultrasound-sensitive vehicles have the potential to treat
tumorigenic cancers due to their invasive character, abil-
ity to penetrate deeply into the human body, and ease of
control. In 2002, Pruitt and Pitt investigated ultrasound-
mediated doxorubicin release using stabilized Pluronic
P105 micelles [66]. Doxorubicin was encapsulated
within polymeric micellesc o m p o s e do f1 0 %P l u r o n i c
P105 and N,N-diethylacrylamide and delivered systemi-
cally to rats. Application of low-frequency ultrasound at
the tumor site resulted in doxorubicin release; this
resulted in a significant reduction in tumor volume. Lin
et al. have investigated the physical and chemical prop-
erties of lipid membranes subjected to ultrasound treat-
ment [67]. They showed that high permeability resulting
from ultrasound treatment is correlated with lipid pack-
ing and can be useful for efficient drug release and
ultrasound-mediated DNA transfection. In 2007, Ferrara
et al. reviewed that small gas bubbles, used to enhance
Nucleus
Endosomal
release
Endocytosis 
Endosome
Gene
transfection
pH-sensitive
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Figure 3 Schematic illustration of the delivery of pH-sensitive gene carriers. For example, the DMAEMA/HEMA nanoparticle releases DNA
in the low pH endosome [49].
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c a t i o n sa n dm o n i t o r i n g[ 6 8 ] .W h e nd r i v e nb ya nu l t r a -
sonic pulse, small gas bubbles oscillate with a wall
velocity on the order of tens to hundreds of meters per
second and can be deflected to a vessel wall or fragmen-
ted into particles on the order of nanometers. Also, a
focused ultrasound beam can be used for disruption of
delivery vesicles and blood vessel walls, which offer the
opportunity to locally deliver a drug or gene. Ultrasound
does not damage the surrounding tissue, making it
attractive for triggering drug release.
Biomolecule-responsive drug delivery
The presence of biomolecules specific to an organ or
disease state may be useful to regulate the release of
drugs. Biomolecules can either participate in a chemical
reaction or result in cleavage of a chemical bond. In this
section, we will discuss the use of hydrogels that are (1)
responsive to glucose and (2) use enzymes to facilitate
hydrogel degradation.
Glucose-responsive hydrogels have been investigated
for self-regulating the release of insulin for the treat-
ment of diabetes. Early studies have been largely based
on the combination of glucose oxidase with polyelectro-
lyte hydrogels that exhibit pH-responsive swelling or
shrinking behavior [69,70]. As glucose diffuses within
the hydrogel, entrapped glucose oxidase catalyzes its
conversion to gluconic acid, lowering the local pH of
the gel and resulting in swelling and the subsequent
release of insulin. However, the efficiency of glucose oxi-
dase decreases with pH. PNIPAm coupled with phenyl-
boronic acid has been investigated as a glucose-
responsive system [71,72]. Introduction of phenylboro-
nic acid decreases the volume phase transition tempera-
ture. The hydrogel swells in the presence of glucose.
More recently, Miyata et al. demonstrated that biomole-
cular complexes such as the carbohydrate-binding lectin,
concanavalin A (Con. A), could be coupled with PNI-
PAm to achieve reversible swelling or shrinking in
response to stepwise changes in glucose concentration
[73]. Zhang et al. also utilized Con. A as the cross-linker
for carboxymethyl dextran (CM-dextran) based hydro-
gels. Competitive displacement between Con. A and
terminal glucose moieties on dextran by free glucose
changed both the morphology and permeability of the
gel [74]. Although these systems triggered insulin release
through volumetric changes, regulating the rate and
reliability of release remains a challenge.
Researchers have also exploited the presence of site or
disease specific enzymes in drug delivery by incorporat-
ing enzyme-cleavable peptides within hydrogels. For
example, Aimetti et al. prepared a PEG hydrogel drug
delivery system which incorporated human neutrophil
elastase (HNE)-sensitive linkers for the treatment of
inflammation. HNE is a serine protease secreted by neu-
trophils, which accumulates at sites of inflammation.
HNE-sensitive peptides were synthesized using solid
phase Fmoc chemistry and their degradation kinetics
were characterized. The rate of substrate degradation
can be tailored by the incorporation or substitution of
specific amino acids. Local, controlled release from
hydrogels containing HNE-sensitive peptides was
achieved in the presence of HNE as visualized by fluor-
escence energy resonance transfer (FRET) [75].
Growth factor delivery, controlled by enzymes
involved in tissue regeneration, has also been investi-
gated. Sakiyama-Elbert et al. designed the delivery of
beta-nerve growth factor (b- N G F )f r o mf i b r i nm a t r i c e s
as a nerve regeneration therapy. They synthesized b-
NGF fusion proteins with an enzymatically degradable
linker that served as the covalent anchor to the fibrin
matrix and thus prevented a potential loss of enzymatic
activity [76]. Researchers have also exploited the
enzyme-triggered degradability of certain prodrugs. Ped-
ersen et al. investigated anti-cancer retinoid lipophilic
drugs that are covalently attached to phospholipids.
These prodrugs have a lipid backbone that is degradable
by secretory phospholipase A2 (sPLA2) IIA. The pro-
drugs self-assembled into liposomes, which were suscep-
tible to degradation by (sPLA2) IIA. In vitro studies
utilizing MT-3 breast carcinoma and HT-29 colon ade-
nocarcinoma cell lines demonstrated high cytotoxicity of
prodrug liposomes only in the presence of the (sPLA2)
IIA enzyme [77].
Magnetic-sensitive drug delivery
Magnetic drug delivery systems possess three main
advantages: (1) visualization of drug delivery vehicles,
(2) ability to guide and control movement of drug car-
riers through magnetic fields, and (3) thermal heating
which has been used to control drug release or produce
tissue ablation. Magnetic drug carriers like magnetite,
maghemite, cobalt ferrite, and carbonyl iron are biocom-
patible, non-toxic and non-immunogenic [78]. Arias et
al. utilized magnetite to produce magnetic core/shell
nanoparticles for drug delivery. The nanoparticles con-
sisted of a magnetite core with a self-assembling squale-
noyl gemcitabine, an amphiphilic anti-cancer drug, shell.
Optical microscopy images showed the alignment of the
core/shell nanoparticles under the influence of a 0.2 T
magnetic field [78]. Liu et al. reported in vitro and in
vivo studies of poly[aniline-co-N-(1-one-butyric acid)]
aniline (SPAnH) nanoparticles encapsulating iron oxide
(Fe3O4). To overcome the blood-brain barrier, the
authors utilized focused ultrasound to temporarily dis-
rupt the barrier and increase permeability. Their results
showed that an estimated 0.16 ± 0.03 mM of magnetic
nanoparticles were delivered to brain tumors in
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higher than the therapeutic range [79]. Magnetic nano-
particles have also been proposed as a component in
drug eluting stents for the treatment of vascular dis-
eases. Chorny et al. reported the use of polylactide
nanoparticles incorporating magnetite nanocrystals and
encapsulating paclitaxel. In vitro studies demonstrated
cell growth inhibition with a relatively low dose and
brief (five minute) magnetic field exposure. In vivo stu-
dies performed in a rat carotid artery model of stent
restenosis showed a significant benefit over the control
group. Additionally, 13.2 ± 2.0 μg of magnetic nanopar-
ticles delivered to the stented carotid segment under a
magnetic field were retained in the artery compared to
only 3.4 ± 1.9 μg of particles delivered without a mag-
netic field [80].
Magnetic nanoparticles have also been encapsulated
within liposomes. da Silva Gomes et al. synthesized lipo-
somes encapsulating magnetic nanoparticles with an
outer polyelectrolyte shell using a layer by layer deposi-
tion technique. The lipid vesicles were characterized by
dynamic light scattering, cryo-transmission electron
microscopy and atomic force microscopy. Polyelectrolyte
coated-liposomes were highly stable as they showed no
significant membrane disruption or leakage of encapsu-
lated contents in the presence of detergent Triton TX-
100 [81].
Multiple responsive-matrices in drug delivery
Substantial benefits may be gained from the develop-
ment of polymeric macromolecules that are responsive
to small environmental changes and consequently elicit
a response. Despite the many advances that have been
accomplished, the field of stimuli-responsive biomater-
ials still faces many challenges. Most of the “smart”
materials that have been investigated are primarily
focused on a single type of stimulus. Developing a mate-
rial that is responsive to more than one stimulus may
combine the delivery of a drug with other capabilities
such as detection, imaging, or feedback. Attention has
been focused on materials that respond to more than
one stimulus (Table 2).
Temperature- and pH-responsive matrices
Temperature- and pH-responsive matrices have been
extensively studied in drug delivery because these two
parameters often deviate from the norm in diseased tis-
sue. Both environmental changes offer the ability for
self-regulated control over the delivery of a drug, avoid-
ing the need for external stimuli. Poly(N-isopropylacry-
lamide-co-methacrylic acid) and PNIPAm are well-
established thermo-responsive polymers [6,38,82-94].
These polymers may be combined with pH-responsive
polymers, like AA and its alkyl esters such as MAA
[6,82,85,94,95]. Zhang et al. prepared temperature and
pH-responsive nanoparticles from combinations of PNI-
PAm and MAA at different molar ratios [82]. The rela-
tive permeability of the nanoparticles increased
significantly when the temperature was increased from
37°C to 43°C and when the pH decreased from 6 to 4.
Nanoparticles encapsulating vitamin B12 exhibited a par-
tition coefficient that decreased from 0.8 to 0.3 with
increasing temperature and decreased from 0.8 to 0.6
with decreasing pH. Gu et al. prepared PNIPAm-co-AA
hydrogels with hollow “cages” [6]. They showed that iso-
niazid (INH), an antitubercular drug, was located inside
t h ec a v i t yo ft h eg e l“cages” and also within the shell.
The “cages,” which were synthesized by SiO2-templated
polymerization, had a silica core that was subsequently
etched away by hydrofluoric acid leaving a hollow inter-
ior. The hydrodynamic diameter of the hydrogel “cages”
decreased from 367 nm to 200 nm with increasing tem-
perature and decreasing pH. Salehi et al. synthesized an
injectable hydrogel system composed of PNIPAm, acry-
lamide (AAm), and vinyl pyrrolidone (VP) to encapsu-
late naltrexone, an opiate receptor antagonist [94]. The
swelling ratios of the gel increased when the pH
decreased from 8.5 to 7.4 and decreased when the tem-
perature increased from 25°C to 37°C. They also per-
formed in vitro release studies where a low burst effect
and a slow release profile of naltrexone was observed
over the course of 28 days.
In addition to PNIPAm, other temperature-responsive
polymers have been investigated in dual-responsive drug
delivery systems [41,96-100]. Moon et al. prepared and
characterized amphiphilic, pH- and temperature-respon-
sive polyaspartamide derivatives, which formed micelles
with an average diameter of 100 nm at 25°C [41]. A sol-
gel transition was observed when the temperature was
increased from 15°C to 25°C and when the pH was
increased from 6 to 10. Ding et al. fabricated injectable
hydrogels based on glycol chitosan and benzaldehyde-
capped poly(ethylene glycol)-block-poly(propylene gly-
col)-block-poly(ethylene glycol) (PEO-PPO-PEO) [98]. In
vivo tests using a rat model demonstrated that the
hydrogel underwent a sol-gel transition at physiological
conditions. These hydrogels have the ability to encapsu-
late both hydrophilic and hydrophobic drugs and can
control the release profile by varying temperature or pH.
Light- and pH- or temperature-responsive matrices
Light-responsive materials are combined with a second-
ary stimulus such as temperature or pH to increase
control over drug release. Light responsiveness is
usually introduced to a temperature or pH-sensitive
material by conjugating a photo-reactive moiety [95].
Jochum et al. synthesized a thermo- and light-respon-
sive polyacrylamide copolymer having salicylideneaniline
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merizes from the enol to keto form and changes its
dipole moment upon exposure to UV light. To synthe-
size the polymer, the authors performed a double poly-
mer analogous reaction of poly(pentafluorophenyl
acrylate) (PPFPA) and varied the molar composition of
salicylideneaniline from 1 to 15 mol%.
Light- and pH-responsive materials have also been
investigated. Angelatos et al. designed light- and pH-
responsive polyelectrolyte/gold nanoparticle microcap-
sules via the layer by layer colloid-templating method
[58]. Microcapsules were prepared by depositing the
electrolytes poly(sodium 4-styrenesulfonate) (PSS) and
poly(allylamine hydrochloride) (PAH) in a layer by layer
fashion onto a template of melamine formaldehyde
(MF) microparticles. The MF core was subsequently
etched away with hydrochloric acid, and gold nanoparti-
cles were introduced into the microcapsule shell. Fluor-
escein isothiocyanate (FITC)-dextran was encapsulated
and was shown to be released after a decrease in pH
and upon irradiation of 10 ns pulses of light at 1064 nm.
Magnetic- and pH- or temperature-responsive matrices
Magnetic fields can be remotely applied to localize drug
carriers and to induce a temperature change. There
have not been an extensive number of studies focusing
on magnetic- and temperature-responsive materials, but
this area has received increasing attention within the
last few years [102-106]. Luo et al. prepared micro-
spheres by encapsulating silica-coated superparamag-
netic magnetite nanoparticle clusters with a crosslinked
PNIPAm shell [105]. The microspheres exhibited a tem-
perature-dependent swelling ratio; the hydrodynamic
diameter decreased from 750 nm to 500 nm when the
temperature increased from 20°C to 60°C. Additionally,
the microspheres had greater magnetic responsivity at
temperatures higher than the volume phase transition
temperature due to the decrease in size at higher tem-
peratures. A faster separation-redispersion behavior of
the microspheres was observed at 60°C, above the
volume phase transition temperature, compared to that
at 25°C. In another study, a different temperature-
responsive material, poly(ethyleneimine)-modified poly
(ethylene oxide)-poly(propylene oxide)-poly(ethylene
oxide) (PEO-PPO-PEO) block copolymer, was used
instead of PNIPAm to coat iron oxide nanoparticles
[102]. The nanoparticle hydrodynamic diameter
decreased from 45 to 25 nm when the temperature
increased from 20°C to 35°C. One of the most attractive
features of this drug delivery system is the ability to
reversibly control the payload release by changing the
PEO-PPO-PEO polymer shell conformation. The poly-
mer shell acts as a gate; it is in an extended conforma-
tion at room temperature but changes to a coiled
conformation upon heating to 37°C. In vitro release of
hydrophobic and hydrophilic model drugs was achieved
by switching the temperature from 37°C to 20°C. In
addition, the nanoparticles showed good biocompatibil-
ity and effective nerve regeneration when loaded with a
ganglioside in a spinal cord injury rat model.
Magnetic- and pH-responsive materials have also been
investigated [107-110]. Superparamagnetic Fe3O4 nano-
particles were coated with different pH-responsive block
copolymers [109]. Four different block copolymers,
methoxypoly(ethylene glycol)-b- (N,N-diethylamino)
ethyl methacrylate-b-poly(glycidyl methacrylate)
(MPEG-b-PDEAEMA-b-PGMA), methoxypoly(ethylene
glycol)-b-(N,N-diethylamino)methyl methacrylate-b-poly
(glycidyl methacrylate) (MPEG-b-PDMAEMA-b-
PGMA), PDEAEMA-b-PGMA and MPEG-b-PGMA,
were synthesized. The block copolymers were conju-
gated to the surface of Fe3O4 nanoparticles stabilized
with HClO4 via a ligand exchange method. The authors
performed drug release studies with MPEG-b-
PDEAEMA-b-PGMA-Fe3O4 and MPEG-b-PDMAEMA-
b-PGMA-Fe3O4 nanocarriers encapsulating chlorambu-
cil (CLB), an anti-cancer agent, and indomethacin
(IND), an anti-inflammatory agent. Their results showed
Table 2 Multiple stimuli-sensitive drug delivery
Stimuli Carrier type Payload Reference
Temperature/pH PNIPAm/MAA Vitamin B12 [82]
PNIPAm/AA Isoniazid [6]
PNIPAm/AAm/VP Naltrexone [94]
Light/pH or light/
temperature
Polyacrylamide/Salicylideneaniline None reported [101]
PSS/PAH/Au FITC-dextran [58]
Magnetic/temperature or
magnetic/pH
PEO/PPO/PEO/Fe2O3 Ibuprofen and Eosin Y [102]
PNIPAm/g-Fe2O3/SiO2 None reported [105]
MPEG-b-PDEAEMA-b-PGMA, MPEG-b-PDMAEMA-b-PGMA, PDEAEMA-b-PGMA
and MPEG-b-PGMA/Fe3O4
Chlorambucil and
indomethacin
[109]
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Page 8 of 12that upon a decrease in pH (below the pKa of each
drug), the percentage of drug release increased up to
90% for CLB and 70% for IND. At pH 7.4 the percent
of drug release for both IND and CLB was approxi-
mately 25%.
Concluding remarks
The ability to alter the biodistribution of a drug by
modulating its release profile through the use of smart
polymers could transform drug delivery from passive
controlled release to active stimuli-regulated delivery.
Altering the drug biodistribution has the ability to
reduce toxicity and side effects while improving thera-
peutic outcomes due to the ability to deliver higher
doses of drug to the site of interest. The stimuli-respon-
sive polymers reviewed here serve to provide a snapshot
of the utility and complexity of polymers that can sense,
process, and respond to stimuli in modulating the
release of a drug. Stimuli-responsive drug delivery vehi-
cles come in the form of polymersomes [111,112], lipo-
somes [113-115], micelles [116-118], and dendrimers
[119,120]. All of these systems aim to deliver an effec-
tive dose of drug at a specific time and place.
Despite many advances, there are still numerous
challenges and opportunities that exist to translate
responsive polymers from the laboratory the clinic.
There is a need to develop polymers with greater sen-
sitivity to a more diverse range of stimuli. In terms of
biochemical signals or biomarkers, this is usually in
the range of nano to picomolar concentrations [121].
This may require both a highly sensitive sensing
mechanism and/or an amplification system to elicit a
response from the polymer. In terms of the physical
microenvironment, there are only minor differences in
pH and temperature between diseased and normal tis-
sues. Therefore, smart polymers must be able to accu-
rately sense the changes in their surroundings to target
drug release.
There is also a significant opportunity for smart poly-
mers to respond to multiple stimuli. Hybrid polymers
created in this manner will offer more parameters to
tune drug delivery, which may be necessary for more
complex and dynamic environments. It is worth noting
that in addition to drug delivery applications, smart
polymers in general have broad applications in tissue
engineering and regenerative medicine (e.g. as injectable
systems for delivery of cells or self-regulating scaffolds
for cell growth or infiltration), and in actuators (e.g. as
smart valves and coating in microfluidics or shape mem-
ory devices). Given the continuous development of new
responsive polymer compositions, we expect increasingly
elaborate and versatile drug carriers to be introduced in
the future.
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